Review article
Clinical scales for multiple sclerosis

https://doi.org/10.1016/0022-510X(95)00261-YGet rights and content

Abstract

Many neurological rating scales have been suggested to assess the impact of multiple sclerosis on patients, but none has been universally accepted. The Kurtzke Extended Disability Status Scale has been the most widely used despite its imperfections. It combines disability and impairment, has moderate inter-rater reliability, and its overall score is heavily weighted toward ambulation. The Scripps Neurological Rating Scale attempts to quantify impairment as measured by the traditional neurological examination. However, this and other impairment scales lack direct relevance to patients' functional health status. The Ambulation Index and some of the quantitative upper limb dysfunction assessment methods are sensitive and reproducible, but they only measure limited aspects of the wide range of disabilities encountered in multiple sclerosis. Current scales of disability and activities of daily living, such as the Incapacity Status Scale and the Functional Independent Measure, are not sensitive to the type of change which occurs in multiple sclerosis. The relationship between abnormalities on magnetic resonance images of the brain and disability has been difficult to ascertain. Although recently developed imaging acquisition methods may demonstrate abnormalities which are more closely correlated with disability, the demonstration of prevention, stabilization or recovery from disability using clinical scales will remain the final arbiter of success in clinical trials. We suggest guidelines for an improved disability scale.

References (79)

  • W.W. Beatty et al.

    Metamemory in multiple sclerosis

    J. Clin. Exp. Neuropsychol.

    (1991)
  • A.T. Beck et al.

    An inventory for measuring depression

    Arch. Gen. Psychiat.

    (1961)
  • L. Brosseau et al.

    The inter-rater reliability and construct validity of the Functional Independent Measure for multiple sclerosis subjects

    Clin. Rehabil.

    (1994)
  • C. Confavreux

    Establishment and use of the multiple sclerosis register-EDMUS

    Ann. Neurol.

    (1994)
  • C. Confavreux et al.

    EDMUS, a European database for multiple sclerosis

    J. Neurol. Neurosurg. Psychiat.

    (1992)
  • M.K. Edwards et al.

    Multiple sclerosis: MRI and clinical correlation

    Am. J. Roentgenol.

    (1986)
  • G.W. Ellison et al.

    A placebo-controlled, randomised, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis

    Neurology

    (1989)
  • G.W. Ellison et al.

    Responsiveness os the disability status scale (DSS) (abstract)

    Neurology

    (1993)
  • G.W. Ellison et al.

    Design strategies in multiple sclerosis clinical trials

    Ann. Neurol.

    (1994)
  • M. Filippi et al.

    Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

    Neurology

    (1994)
  • M. Filippi et al.

    Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

    Neurology

    (1995)
  • D.A. Francis et al.

    An assessment of disability rating scales used in multiple sclerosis

    Arch. Neurol.

    (1991)
  • G.M. Franklin et al.

    Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis

    Neurology

    (1988)
  • A. Gass et al.

    Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis

    Ann. Neurol.

    (1994)
  • D.P. Goldberg et al.

    A scaled version of the General Health Questionnaire

    Psychol. Med.

    (1979)
  • D.E. Goodkin et al.

    Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests

    Arch. Phys. Med. Rehabil.

    (1988)
  • D.E. Goodkin et al.

    Exacerbation rate and adherence to disease type in a prospective followed-up population with multiple sclerosis. Implications for clinical trials

    Arch. Neurol.

    (1989)
  • D.E. Goodkin et al.

    Inter-and intrarater variability for grades 1.0–3.5 Kurtzke Expanded Disability Status Scale (EDSS) (abstract)

    Neurology

    (1991)
  • D.E. Goodkin et al.

    Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Extended Disability Status Scale (EDSS)

    Neurology

    (1992)
  • D.E. Goodkin et al.

    Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

    Ann. Neurol.

    (1995)
  • C.V. Granger et al.

    Functional assessment scales: a study of persons with multiple sclerosis

    Arch. Phys. Med. Rehabil.

    (1990)
  • K.M. Hall et al.

    Characteristics and comparisons of functional assessment indices: Disability Rating Scale, Functional Independent Measure, and Functional Assessment Measure

    J. Head Trauma Rehabil.

    (1993)
  • B.B. Hamilton et al.

    A uniform national data system for medical rehabilitation

  • M. Hamilton

    A rating scale for depression

    J. Neurol. Neurosurg. Psychiat.

    (1960)
  • S.L. Hauser et al.

    Intensive immunosuppression in progressive multiple sclerosis

    N. Engl. J. Med.

    (1983)
  • R.K. Heaton et al.

    Neuropsychological findings in relapsing-remitting and chronic progressive multiple sclerosis

    J. Consult. Clin. Psychol.

    (1985)
  • W.G. Henderson et al.

    Training examiners to administer a quantitative neurological examination for a multicenter clinical trial

    Arch. Phys. Med. Rehabil.

    (1975)
  • M.J. Hohol et al.

    Disease steps in multiple sclerosis: a simple approach to evaluate disease progression

    Neurology

    (1995)
  • International Federation of Multiple Sclerosis Societies

    Minimal Record of Disability

    Acta Neurol. Scand.

    (1984)
  • Cited by (0)

    View full text